Differential Expression of HPV16 L2 Gene in Cervical Cancers Harboring Episomal HPV16 Genomes: Influence of Synonymous and Non-Coding Region Variations

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Mandal, Paramita ^a   Bhattacharjee, Bornali ^b,e   Das Ghosh, Damayanti ^b,f   Mondal, Nidhu Ranjan ^c   Roy Chowdhury, Rahul ^c   Roy, Sudipta ^d   Sengupta, Sharmila ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c Saroj Gupta Cancer Centre and Research Institute   (India)

^d Kothari Medical Centre 8/3   (India)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 548A-5P; MICRORNA 548D-5P; UNCLASSIFIED DRUG; CAPSID PROTEIN; L2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; MIRN548 MICRORNA, HUMAN; ONCOPROTEIN;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; BINDING SITE; CODON; CONTROLLED STUDY; EPISOME; ETHNIC GROUP; EUROPEAN; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CODE; GENETIC CORRELATION; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; L2 GENE; OPEN READING FRAME; PATHOGENESIS; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; WART VIRUS; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PLASMID; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICRORNAS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 84878775736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065647     Document Type: Article

References (59)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen A, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796-802.
2. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, et al. (1995) Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69: 7743-7753.
3. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 348: 518-527.
4. Das BC, Gopalkrishna V, Hedau S, Katiyar S, (2000) Cancer of the uterine cervix and human papillomavirus infection. Curr Sci 78: 52-63.
5. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, et al. (2005) Prevalence and distribution of high-risk human papillomavirus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 5: 116.
6. Singh RK, Maulik S, Mitra S, Mondal RK, Basu PS, et al. (2006) Human papillomavirus prevalence in post radiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease. Int J Gynecol Cancer 6: 1048-1054.
7. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahé C, et al. (2005) Papillomavirus infection in rural women in southern India. Br J Cancer 92: 601-606.
8. Laikangbam P, Sengupta S, Bhattacharya P, Duttagupta C, Singh D, et al. (2007) A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int J Gynecol Cancer 17: 107-117.
9. Andrea MD, Mondini M, Azzimonti B, Dell'Oste V, Germano S, et al. (2007) Alpha- and beta papillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res 124: 220-225.
10. Zur Hausen H, (1996) Papillomavirus infections - a major cause of human cancers Biochim. Biophys Acta 1288: F55-F78.
11. Doorbar J, (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 110: 525-541.
12. Schwarz E, Freese UK, Gissman L, Mayer W, Roggenbuck B, et al. (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-114.
13. Hawley-Nelson PK, Vousden H, Hubbert NL, Lowy DR, Schiller JT, (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910.
14. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R, (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421.
15. Cromme FV, Meijer CJ, Snijders PJ, Uyterlinde A, Kenemans P, et al. (1993) Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67: 1372-1380.
16. Kalantari M, Blennow E, Hagmar B, Johansson B, (2001) Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Pathol 10: 46-54.
17. Wentzensen N, Vinokurova S, Von Knebel Doeberitz M, (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract,. Cancer Res 64: 3878-3884.
18. Bhattacharjee B, Sengupta S, (2006) HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol Oncol 100: 372-378.
19. Narayanan S, Abraham P, Peedicayil A, Sridharan G, Shaji RV, et al. (2004) E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol Oncol 95: 363-369.
20. Das D, Bhattacharjee B, Sen S, Mukhopadhyay I, Sengupta S, (2010) Association of viral load with HPV16 positive cervical cancer pathogenesis: Causal relevance in isolates harboring intact viral E2 gene. Virology 402: 197-202.
21. Bhattacharjee B, Mandal NR, Roy S, Sengupta S, (2008) Characterisation of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 377: 143-150.
22. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, et al. (2008) Virus Attenuation by Genome-Scale Changes in Codon Pair Bias. Science 320: 1784-1787.
23. Bhattacharjee B, Sengupta S, (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354: 280-285.
24. Bhattacharya P, Sengupta S, (2007) Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70: 283-293.
25. Myers G, Delius H, Icenogle J, Bernard HU, Favre M, et al. (1997) Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics. Los Alamos National Laboratory, Los Alamos, New Mexico.
26. Maki H, Fujikawa-Adachi K, Yoshie O, (1996) Evidence for a promoter-like activity in the short non-coding region of human papillomaviruses. J Gen Virol 77: 453-458.
27. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, et al. (2008) MiRNAs expressed by herpes simplex virus1 during latent infection regulate viral mRNAs. Nature 454: 780-783.
28. Griffiths Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ, (2006) miRBase: miRNA sequences, targets and gene nomenclature. Nucl Acids Res 34: D140-D144.
29. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6.
30. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57: 289-300.
31. Das Ghosh D, Bhattacharjee B, Sen S, Premi L, Mukhopadhyay I, et al. (2012) Some Novel Insights on HPV16 Related Cervical Cancer Pathogenesis Based on Analyses of LCR Methylation, Viral Load, E7 and E2/E4 Expressions. PLoS ONE 7 (9): e44678.
32. Miligan SG, Veerapraditsin T, Ahamet B, Mole S, Graham SV, (2006) Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360: 172-181.
33. Sun M, Gao L, Liu Y, Zhao Y, Wang X, et al. (2012) Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China. PLoS ONE 7 (5): e36577.
34. Sabol I, Matovina M, Gasperov NM, Grce M, (2008) Identification of a novel human papillomavirus type 16 E1 gene variant with potentially reduced oncogenicity. J Med Virol 80: 2134-40.
35. Bogovac Z, Lunar MM, Kocjan BJ, Seme K, Jančar N, et al. (2011) Prevalence of HPV 16 genomic variant carrying a 63 bp duplicated sequence within the E1 gene in Slovenian women. Acta Dermatovenerol Alp Panonica Adriat 3: 135-9.
36. Leifer I, Hoeper D, Blome S, Beer M, Ruggli N, (2011) Clustering of classical swine fever virus isolates by codon pair bias. BMC Res Notes 4: 521.
37. Qian W, Yang J-R, Pearson NM, Maclean C, Zhang J, (2012) Balanced Codon Usage Optimizes Eukaryotic Translational Efficiency. PLoS Genet 8 (3): e1002603.
38. Levy JP, Muldoon RR, Zolotukhin S, Link CJ, (1996) Jr. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nat Biotechnol 14: 610-614.
39. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N, (1996) A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70: 4646-4654.
40. Wells KD, Foster JA, Moore K, Pursel VG, Wall RJ, (1999) Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res 8: 371-381.
41. Chow LT, Nasseri M, Wolinsky SM, Broker TR, (1987) Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol 61: 2581-2588.
42. Chow LT, Reilly SS, Broker TR, Taichman LB, (1987) Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J Virol 61: 1913-1918.
43. Baker CC, Howley PM, (1987) Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J 6: 1027-1035.
44. Rohlfs M, Winkenbach S, Meyer S, Rupp T, Durst M, (1991) Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type- 16. Virology 183: 331-342.
45. Halvorsen M, Martin JS, Broadaway S, Laederach A, (2010) Disease-Associated Mutations That Alter the RNA Structural Ensemble. PLoS Genet 6 (8): e1001074.
46. Bartel DP, (2004) MiRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
47. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D, (2005) SV40-encoded miRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686.
48. Lytle JR, Yario TA, Steitz JA, (2007) Target mRNAs are repressed as efficiently by miRNA-binding sites in the 5′UTR as in the 3′UTR. Proc Natl Acad Sci USA 104: 9667-9672.
49. Li Y, Xie J, Xu X, Wang J, Ao F, et al. (2012) MiRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1. Protein and Cell doi:10.1007/s13238-012-2081-y.
50. Zhou J, Liu WJ, Peng SW, Sun XY, Frazer I, (1999) Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol 73 (6): 4972-82.
51. Fahey LM, Raff AB, Da Silva DM, Kast WM, (2009) A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape. J Immunol 183: 6151-6156.
52. Philippa M O'Brien, Saveria Campo M. (2003) Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends in Microbiology. Vol. 11, Issue 7, pp. 300-305.
53. Kim SH, Samal SK, (2010) Role of Untranslated Regions in Regulation of Gene Expression, Replication, and Pathogenecity of Newcastle Disease Virus Expressing Green Fluorescent Protein. J Virol 84: 2629-2634.
54. Cumming SA, Cheun-Im T, Milligan SG, Graham SV, (2008) Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans 36: 522-524.
55. Johansson C, Somberg M, Li X, Backström Winquist E, Fay J, et al. (2012) HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J 31: 3212-27.
56. Day PM, Lowy DR, Schiller JT, (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307: 1-11.
57. Day PM, Baker CC, Lowy DR, Schiller JT, (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci USA 101: 14252-14257.
58. Görnemann J, Hofmann TG, Will H, Müller M, (2002) Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins. Virology 303: 69-78.
59. Darshan MS, Lucchi J, Harding E, Moroianu J, (2004) The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J Virol 78: 12179-88.